Skip to content
Welcome, thoughtbot's Giant Robots listeners!Start here
Pandemics and Biosecurity
24MAY

Hondius hantavirus cluster hits 12 cases

2 min read
16:06UTC

The Andes hantavirus cluster aboard the cruise ship MV Hondius reached 12 cases and three deaths, with passengers now traced across 12 countries after the ship docked at Rotterdam.

ScienceDeveloping
Key takeaway

A person-to-person hantavirus aboard one ship has become a 12-country tracing exercise.

The Andes hantavirus cluster aboard the cruise ship MV Hondius reached its 12th case, with three deaths, as of 24 May, according to the European Centre for Disease Prevention and Control (ECDC)⁠1. The ship docked at Rotterdam on 18 May, and passengers have now been traced across 12 countries; ECDC's surveillance update confirmed one new case since 12 May, when the count stood at 11 across six countries.

Andes virus is the only hantavirus known to pass between people, which is why a single voyage becomes an international tracing exercise rather than a contained shipboard event. The slowing pace, one new case in twelve days against the earlier risk upgrade from low to moderate, suggests the cluster is being tracked rather than running ahead of the response. The open question is the dispersed cohort: a dozen national health systems now each hold a fragment of one passenger manifest.

Deep Analysis

In plain English

The MV Hondius is an Antarctic cruise ship. After its last voyage from Ushuaia, Argentina, several passengers tested positive for Andes hantavirus, a rare lung disease caused by a virus found in rodent droppings in South American wilderness areas. Andes hantavirus is unusual because, unlike other hantaviruses, it can spread between people in close household contact, which is what made this cluster particularly concerning when it first emerged. As of 24 May 2026, 12 passengers are confirmed or probable cases, three have died, and passengers have been traced to 12 countries. The ECDC (the EU's disease agency) confirmed only one new case since 12 May, which suggests the cluster is slowing. People WHO were on the ship are being monitored, typically for 21 days after last exposure.

First Reported In

Update #4 · Ebola triples, response misfires

European Centre for Disease Prevention and Control· 24 May 2026
Read original →
Causes and effects
This Event
Hondius hantavirus cluster hits 12 cases
A person-to-person hantavirus on a ship turns a single voyage into a 12-country contact-tracing problem.
Different Perspectives
IGWG co-chair Tovar da Silva Nunes
IGWG co-chair Tovar da Silva Nunes
The Brazilian co-chair closed the eighth pathogen-sharing session on 18 September without an agreed annex text, the second session in a row to end that way. He presented the outcome as continued commitment, with adoption due at the World Health Assembly in May 2027.
Fraport
Fraport
The Frankfurt Airport operator has told staff to watch for fever, hessenschau reported, after six airport workers caught malaria. Germany does not require insecticide spraying of arriving aircraft cabins, and parasite genotyping to trace the source is due at the end of October.
European Centre for Disease Prevention and Control
European Centre for Disease Prevention and Control
ECDC reported the eight Frankfurt Airport malaria cases on 18 September and considers repeated arrivals of infected mosquitoes on aircraft likely. It has not ruled out local mosquitoes, and awaits genotyping due at the end of October.
Pan American Health Organization
Pan American Health Organization
PAHO counted 53,957 measles cases in the Americas by 19 September and is supporting Peru's response in Puno and Arequipa. It warns that October's Señor de los Milagros festivities and Pope Leo XIV's November visit could increase transmission.
Bangladesh Directorate General of Health Services
Bangladesh Directorate General of Health Services
The DGHS recorded 1,030 measles-related deaths and 172,720 suspected cases by 14 September, after a campaign that reached 19.75 million children. Its disease-control director, Halimur Rashid, said further vaccination rounds were expected within two weeks.
Minapharm
Minapharm
The Egyptian drugmaker and its Berlin subsidiary ProBioGen were awarded up to US$16.5m by CEPI on 27 August to take a Bundibugyo vaccine into a Phase 1 trial in Africa. Final manufacture is planned for Cairo, making it CEPI's first Bundibugyo candidate with an African producer.